Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.
Gladstone
Douglas E
DE
Department of Medicine, Long Island Cancer Center, SUNY Stony Brook , Stony Brook, NY 11794, USA. dgladstone@notes.cc.sunysb.edu
Golightly
Marc G
MG
Zamkoff
Kenneth W
KW
D017338:Cladribine / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D017338:Cladribine; D009173:Mycophenolic Acid